Intranasal Insulin for Autism Spectrum Disorder in Children and Young Adults Aged 4 to 21 Years

Clinical trial NCT07521371 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07521371
Sponsor: Healing Hope International
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Autism Spectrum Disorder Autism Spectrum Disorder (ASD)Autism Spectrum Disorder High-Functioning Autism Spectrum Disorder With Absence of Functional Language Autism Spectrum Disorder With Impaired Functional Language Autistic Disorder of Childhood Onset With Full Syndrome Autistic Disorders Spectrum Autistic Disorder Autistic Disorder in Children and Adolescents Neurodevelopmental Disorders Neurodevelopmental Disorders (NDD)Neurodevelopmental Disorders and Developmental Abnormalities

Start date: 2026-06-01
Primary completion: 2028-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.